Oct 25 2023 |
Connecticut Follows in the Footsteps of Other Jurisdictions Requiring Registration of Pharmaceutical Representatives |
Sheppard, Mullin, Richter & Hampton LLP |
Oct 25 2023 |
California Bans Several FDA-Authorized Food Additives; New York May Soon Follow |
ArentFox Schiff LLP |
Oct 25 2023 |
DEA Further Extends Flexibilities for Controlled-Substance Prescribing Via Telemedicine |
McDermott Will & Emery |
Oct 25 2023 |
FDA Publishes FY 2021 Pesticide Residue Report |
Keller and Heckman LLP |
Oct 24 2023 |
Congress May Have a Vision for Psychedelic Regulation in the US |
Epstein Becker & Green, P.C. |
Oct 24 2023 |
Stocking Naloxone in the Workplace: What Employers Need to Consider |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
Oct 24 2023 |
Telehealth Update: DEA Extends Flexibility in Prescribing Controlled Substances via Telehealth Through 2024 |
Mintz |
Oct 24 2023 |
FDA Updates Guidance Regarding Scientific Communications to HCPs about Unapproved Uses of Approved/Cleared Medical Devices and Drugs |
Nelson Mullins |
Oct 24 2023 |
DEA Issues Second Temporary Extension of COVID-19 Telemedicine Prescribing Flexibilities, Through 2024 |
Epstein Becker & Green, P.C. |
Oct 24 2023 |
DEA Further Extends COVID-19 Telemedicine Prescribing Flexibilities through December 31, 2024 |
Robinson & Cole LLP |
Oct 24 2023 |
EPA Announces Winners of the 2023 Green Chemistry Challenge Awards |
Bergeson & Campbell, P.C. |
Oct 24 2023 |
FDA Seeks to Increase Regulatory Oversight of Laboratory Developed Tests |
ArentFox Schiff LLP |
Oct 24 2023 |
Lawsuit Alleges Panera’s Caffeinated Lemonade Caused Death |
Keller and Heckman LLP |
Oct 24 2023 |
In This Case, "Primarily" Means A Small Fraction |
Allen Matkins Leck Gamble Mallory & Natsis LLP |
Oct 23 2023 |
OCR Cybersecurity Newsletter Emphasizes Significance of HIPAA Sanction Policies |
Mintz |
Oct 23 2023 |
California Bans Four Federally Cleared Additives From Use in Food |
K&L Gates |
Oct 23 2023 |
FDA Deputy Commissioner for Human Foods Expresses Commitment to Human Foods Program Framework |
Keller and Heckman LLP |
Oct 23 2023 |
Safeguarding AI Innovation in Stem Cell Therapy |
Foley & Lardner LLP |
Oct 22 2023 |
NNI Nanoinformatics Conference and U.S.-EU NanoEHS COR Workshop Will Be Held in November 2023 |
Bergeson & Campbell, P.C. |
Oct 20 2023 |
Dirty Steel-Toe Boots, Episode 20: Marijuana in the Workplace [Podcast] |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
Oct 20 2023 |
APHIS Releases Revised Draft and Response to Comments on Guide for Submitting Permit Applications for Microorganisms Developed Using Genetic Engineering |
Bergeson & Campbell, P.C. |
Oct 19 2023 |
APHIS Releases Revised Guidance for Genetically Engineered Microorganism Applications |
Keller and Heckman LLP |
Oct 18 2023 |
FDA’s Proposed Rule on LDT Regulation and the Debate over Agency Deference |
Sheppard, Mullin, Richter & Hampton LLP |
Oct 18 2023 |
Behavioral Health Law Ledger | October 2023 |
Greenberg Traurig, LLP |
Oct 18 2023 |
California Attorney General Issues Enforcement Advisory Letter to Warn Companies of Responsibility to Disclose Presence of PFAS |
Bergeson & Campbell, P.C. |
Oct 18 2023 |
DOJ's Consumer Protection Branch Continues Civil Enforcement Against Pharmacies, Pharmacists for Opioid Dispensing |
Barnes & Thornburg LLP |
Oct 18 2023 |
OECD Tour de Table Includes Information on U.S. Developments on Human Health and Environmental Safety of Nanomaterials |
Bergeson & Campbell, P.C. |
Oct 18 2023 |
FDA Issues New Enforcement Policy for Face Masks and Barrier Face Coverings |
ArentFox Schiff LLP |
Oct 18 2023 |
Califf Provides Update on Front-of-Package Labeling |
Keller and Heckman LLP |
Oct 17 2023 |
CPSC Signals its Regulatory Interest in PFAS |
Foley & Lardner LLP |
Oct 17 2023 |
Tele-Prescribing Flexibilities Extended Again in Second Temporary Rule |
Sheppard, Mullin, Richter & Hampton LLP |
Oct 17 2023 |
Revamping Cosmetics Safety and Regulation: Updates from FDA on Regulatory Changes under MOCRA. |
Squire Patton Boggs (US) LLP |
Oct 17 2023 |
United Cannabis Corporation v. Pure Hemp Collective Inc. |
Sheppard, Mullin, Richter & Hampton LLP |
Oct 17 2023 |
Pharmacy Benefit Manager Reform: What’s on the Horizon? |
McDermott Will & Emery |
Oct 17 2023 |
The Roundabout: AMCC Litigation and Licensing Update |
Bradley Arant Boult Cummings LLP |
Oct 17 2023 |
Public Meeting on Strategies to Reduce Added Sugar Consumption Set for November |
Keller and Heckman LLP |
Oct 17 2023 |
Is Medical Cannabis an Effective Treatment for Autism? A Recent US DHHS Recommendation Renews Hope for Much Needed Research |
Womble Bond Dickinson (US) LLP |
Oct 17 2023 |
Recent Federal Developments, October 2023 |
Bergeson & Campbell, P.C. |
Oct 16 2023 |
The Fine Print: Avoiding IP Pitfalls in Unlicensed Fonts |
McDermott Will & Emery |
Oct 16 2023 |
FDA Publishes Updated Prior Notice of Imported Food Guidance Document |
Keller and Heckman LLP |
Oct 16 2023 |
Rite Aid Chapter 11 Bankruptcy Filing: Just What the Doctor Ordered |
Stark & Stark |
Oct 14 2023 |
Registration Opens for Nano4Earth Roundtable Discussion on Capture of GHGs |
Bergeson & Campbell, P.C. |
Oct 13 2023 |
McDermottPlus Check-Up: October 13, 2023 |
McDermott Will & Emery |
Oct 13 2023 |
Alive and Well: Daubert Challenges Based on an Expert’s Lack of Qualifications |
Phillips Lytle LLP |
Oct 13 2023 |
Governor Signs Bill Prohibiting Any Grocery Store Purchases Without Prior Written Notice To The Attorney General |
Allen Matkins Leck Gamble Mallory & Natsis LLP |
Oct 12 2023 |
FDA Issues Guidance on Informed Consent for IRBs, Clinical Investigators, and Sponsors [Podcast] |
K&L Gates |
Oct 12 2023 |
California’s Transformational Single-Use Packaging EPR Law Moves Toward Implementation |
Beveridge & Diamond PC |
Oct 12 2023 |
DEA Issues Second Temporary Rule Extending Controlled Substance Prescribing Flexibilities Through December 2024 |
Polsinelli PC |
Oct 12 2023 |
Cell-Cultivated Meat Is Gaining Ground |
Womble Bond Dickinson (US) LLP |
Oct 12 2023 |
DEA Further Extends Telemedicine Prescribing Flexibilities |
Dinsmore & Shohl LLP |